Filing Flows › Comparisons › MGTX vs VIR
MeiraGTx Holdings vs Vir Biotechnology: MGTX and VIR compared
MeiraGTx Holdings is the larger company: $321M of revenue in its latest quarter (Q2 2026) against $239M for Vir Biotechnology (Q2 2026). Vir Biotechnology is growing faster (197× against 87× a year earlier). MeiraGTx Holdings is more profitable, with an operating margin of 76.0% against 30.7%.
Where the money goes: MGTX and VIR
MeiraGTx Holdings (MGTX) · Q2 2026
MeiraGTx Holdings, Q2 2026: revenue $321M (87× year over year), operating margin 76.0%, net earnings $161M, operating cash flow −$38.5M. The chart follows the revenue to costs, profit and cash.
Vir Biotechnology (VIR) · Q2 2026
Vir Biotechnology, Q2 2026: revenue $239M (197× year over year), operating margin 30.7%, net earnings $80.1M, operating cash flow $123M. The chart follows the revenue to costs, profit and cash.
| MeiraGTx Holdings (MGTX) | Vir Biotechnology (VIR) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $321M | $239M |
| Revenue growth, Y/Y | 87× | 197× |
| Operating margin | 76.0% | 30.7% |
| Net earnings | $161M | $80.1M |
| Net margin | 50.0% | 33.5% |
| Operating cash flow | −$38.5M | $123M |
| Free cash flow | — | $123M |
| Market value | $890M | — |
| P/E | 11.3× | — |
| Analysts’ mean target | $27.75 | — |
Where the revenue comes from
MeiraGTx Holdings
- License revenue: $205M (64%)
- Service revenue - related party: $105M (33%)
- Service revenue: $11.9M (4%)
Vir Biotechnology
- License and collaboration revenue: $239M (100%)
- Grant revenue: $11K (0%)
Questions
Which is bigger, MeiraGTx Holdings or Vir Biotechnology?
MeiraGTx Holdings is the larger company: $321M of revenue in its latest quarter (Q2 2026) against $239M for Vir Biotechnology (Q2 2026).
Is MeiraGTx Holdings or Vir Biotechnology growing faster?
Vir Biotechnology is growing faster (197× against 87× a year earlier).
Which is more profitable, MeiraGTx Holdings or Vir Biotechnology?
MeiraGTx Holdings is more profitable, with an operating margin of 76.0% against 30.7%.
More: MeiraGTx Holdings earnings · how MeiraGTx Holdings makes money · Vir Biotechnology earnings · how Vir Biotechnology makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 5, 2026). Fiscal quarters can end on different dates. Not investment advice.